#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurotrophic keratopathy SAPHO syndrome VEXAS syndrome HER2 gene amplification Chordoma Acute graft versus host disease in skin Brain stem glioma Cardiac amyloidosis Fragile X syndrome Restless legs syndrome IPEX syndrome Oesophageal squamous cell carcinoma stage III Chronic graft versus host disease in liver Univentricular heart Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Nephroblastoma – Treatment Uterine leiomyosarcoma – Diagnostics Fabry’s disease – Treatment Angiosarcoma – Diagnostics Rhabdomyosarcoma recurrent – Life with Disease Lysosomal storage disorder – Trials in Disease Shprintzen-Goldberg syndrome Familial amyotrophic lateral sclerosis – Basic Information Primary immunodeficiency syndrome – Life with Disease Marginal zone lymphoma refractory – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nms-03592088 VANDETANIB MB-001 Nafarelin D-Biotin Chlortalidone SAR445399 Darbepoetin Alfa IMMUNOSTEM Acasunlimab Selexipag Doxycycline Fluocinolone Acetonide Peboctocogene Camaparvovec Litifilimab Idecabtagene Vicleucel Co-Trimoxazole CHONDROITIN SULFATE SODIUM Absk021 Hydrochloride Hydrate Tradipitant More therapies…

    Learn about Your Condition

    Angiosarcoma Insulin resistance Eosinophilic oesophagitis Actinic cheilitis Essential hypertension Vaginal haemorrhage Vulvovaginal dryness Vertigo Choroid melanoma Glomerulonephritis membranous Ewing's sarcoma recurrent Metastatic malignant melanoma Amyotrophic lateral sclerosis Restless legs syndrome Anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kat Attica General Hospital

Kat Attica General Hospital

Nikis 2, Kifissia, 145 61, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ticagrelor
    • Acetylsalicylic Acid
    • Clopidogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Emapalumab
    • Sodium Chloride
    Greece

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!